Introduction
Tissue engineering offers promising opportunities to restore cartilage defects. The matrix associated chondrocyte transplantation (MACT) is the most commonly used method to rebuild cartilage for in vivo applications. Despite their biodegradability, the materials of the matrices are artificial substances in both the cartilage transplantat and afterwards in the joint. Therefore we developed a new technology: the scaffold-free cartilage transplantats (SFCT). These transplantats are entirely produced out of differentiated chondrocytes without using scaffolds [1] . In the following we will show the results of our study comparing our newly developed SFCTs and the commonly used MACTs.
Methods
For the production of SFCTs and MACTs equine chondrocytes of the stifle joint were used. Chondrocytes were isolated by enzymatic hydrolysis of cartilage biopsies. After cultivation and proliferation in monolayer cultures cells were converted in a three-dimensional state. Commercially available lactid-respectively collagen-based carriers were taken as matrices. Cells were embedded in matrices according to the manufacturer's instructions with a concentration of 1 Mio/cm². The loaded matrices were cultivated in a floated state in six-well plates (Fa. Greiner). The medium was changed daily. For the production of SFCTs we followed our own patented protocols whereby cyclic manual mechanical stimulation was applied. Thus, we got solid hyaline-like cartilage transplantats with a diameter up to 1.5 cm and a thickness of 1 -3 mm. The cultivation of SFCTs and MACTs took three to four weeks. For biochemical investigations samples were dehydrated, defatted and subsequently tested for their amount of proteoglycans and collagen (ratio µg to mg dehydrated tissue). Furthermore, the concentration of hydroxyproline (collagenspecific amino acid) and glycosaminogylcans (GAG; matrix shaping substance) was measured quantitatively. For histological investigations toluidine blue staining was applied for general screening, alcian blue staining for detecting GAG and Masson Goldner staining for imaging collagen. As control tissue was used native equine joint cartilage.
Results
Figure 1 graphically represents the load cycle of a SFCT after three weeks of cultivation. At that time SFCT shows a force resistance between 1.6 N and 2.3 N. Biochemical investigations indicate that SFCTs (hydroxyproline: 29.3% and GAG: 35%) resemble native cartilage more closely than MACTs (hydroxyproline and GAG: 2%). In contrast to MACTs (Fig.  2 C, D) , the results of histological staining revealed similarities between SFCTs and native cartilage in terms of tissue architecture, cell distribution and morphology (Fig.  2 A, B) after three-respectively four weeks of cultivation in vitro. Only a superficial activity in cell growth and morphology could be observed at both matrices. Deep-seated chondrocytes of MACT samples showed amorphous, tissue atypical phenotypes. Furthermore, the cell concentration in these regions was lower compared to SFCTs and native cartilage. 
Discussion
The results of our comparative study between SFCTs and MACTs showed significant differences between quantitative biochemical and histological results. The used intermittent mechanical stimulation for the SFCT has a positive effect on the synthesis activity of the in vitro cultivated chondrocytes. Meanwhile a significantly lower matrix production could be observed in MACTs. This was also proven by biochemical and histological investigations. The GAG concentration revealed a 17-fold higher and the collagen concentration a 14-fold higher amount in SFCTs than in MACTs. The mechanical strength of the scaffold-free cartilage transplantats at the end of the cultivation explains the differences in the concentration of extracellular matrix proteins and in the cell morphology of the tissue engineering transplantats prepared by the different procedures (SFCT and MACT). Remarkably is, that equal cells (equine, same passage) were used in both techniques. Our results indicate that SFCTs represent a promising and better alternative to restore cartilage defects compared to the common MACT technology. The advantage of the mechanical stimulation during the production process is supposed to be a key factor regarding the healing process and the rapid adaptation of freshly implanted cartilage transplants to the in vivo joint condition.
